The in-vitro activity of linezolid (U-100766) and tentative breakpoints

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 6, 1998, Pages 721-728

  Wise, R ^a   Andrews, J M ^a   Boswell, F J ^a   Ashby, J P ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; DALFOPRISTIN PLUS QUINUPRISTIN; LINEZOLID; METICILLIN; OXAZOLIDINONE DERIVATIVE; TROVAFLOXACIN; VANCOMYCIN;

ANAEROBIC BACTERIUM; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; DOSE TIME EFFECT RELATION; ENTEROBACTERIACEAE; GRAM POSITIVE COCCI; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; STREPTOCOCCUS;

ACETAMIDES; ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; BACTEROIDES FRAGILIS; BACTEROIDES INFECTIONS; COLONY COUNT, MICROBIAL; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; OXAZOLES; OXAZOLIDINONES; TIME FACTORS;

EID: 0032437526     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.6.721     Document Type: Article

References (15)

1. Slee, A. M., Wuonola, M. A., McRipley, R. J., Zajac, I., Zawada, M. J., Bartholomew, P. T. et al. (1987). Oxazolidinones, a new class of synthetic antibacterials: in vitro and in vivo activities of DuP 105 and DuP 721. In Program and Abstracts of the Twenty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 1987. Abstract 244, p. 139. American Society for Microbiology, Washington, DC.
2. Slee, A. M., Wuonola, M. A., McRipley, R. J., Zajac, I., Zawada, M. J., Bartholomew, P. T. et al. (1987). Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721. Antimicrobial Agents and Chemotherapy 31, 1791-7.
3. Ford, C. W., Hamel, J. C., Wilson, D. M., Moerman, J. K., Stapert, D., Yancey, R. J. et al. (1996). In vivo activities of U-100 592 and U-100 766, novel oxazolidinone antimicrobial agents against experimental bacterial infections. Antimicrobial Agents and Chemotherapy 40, 1508-13.
4. Zurenko, G. E., Yagi, B. H., Schaadt, R. D., Allison, J. W., Kilburn, J. O., Glickman, S. E. et al. (1996). In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrobial Agents and Chemotherapy 40, 839-45.
5. Mason, E. O., Lamberth, L. B. & Kaplan, S. L. (1996). In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 40, 1039-40.
6. Jones, R. N., Johnson, D. M. & Erwin, M. E. (1996). In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones. Antimicrobial Agents and Chemotherapy 40, 720-6.
7. Mulazimoglu, L., Drenning, S. D. & Yu, V. L. (1996). In vitro activities of two novel oxazolidinones (U 100592 and U 100766), a new fluoroquinolone (trovafloxacin) and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis. Antimicrobial Agents and Chemotherapy 40, 2428-30.
8. Working Party of the British Society for Antimicrobial Chemotherapy. (1991). A guide to sensitivity testing. Journal of Antimicrobial Chemotherapy 27, Suppl. D, 22-30.
9. Miles, A. A., Misra, S. S & Irwin, J. O. (1938). The estimation of the bactericidal power of the blood. Journal of Hygiene 38, 732-49.
10. National Committee for Clinical Laboratory Standards. (1992). Methods for Determining Bactericidal Activity of Antimicrobial Agents; Tentative Guideline M26-T. NCCLS, Villanova, PA.
11. Metzler, C. M. and DeHaan, R. M. (1974). Susceptibility tests of anaerobic bacteria: statistical and clinical considerations. Journal of Infectious Diseases 130, 588-94.
12. Bostic, G., Perri, M. B., Thal, L. A. & Zervos, M. J. (1995). Comparative in-vitro and bactericidal activity of oxazolidinone antibiotics against multi-drug resistant enterococci. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract 219, p. 151. American Society of Microbiology, Washington, DC.
13. Fass, R. J. (1991). In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci and enterococci. Antimicrobial Agents and Chemotherapy 35, 553-9.
14. Brumfitt, W. & Hamilton-Miller, J. M. T. (1988). In-vitro microbiological activities of DuP 105 and DuP 721, novel synthetic oxazolidinones. Journal of Antimicrobial Chemotherapy 21, 711-20.
15. Peters, J., Kondo, K. L., Lee, R. K., Lin, C. K. & Inderlied, C. B. (1995). In-vitro activity of oxazolidinones against Mycobacterium avium complex. Journal of Antimicrobial Chemotherapy 35, 675-9.